1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hemiplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adunsky, A; Atar, E; Bakoun, M; Hershkowitz, M; Poreh, A | 1 |
| Baumgardt, A; Gill, JC; Leichter, HE; Sheth, KJ | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hemiplegia
| Article | Year |
|---|---|
Infarct volume, neurological severity and PAF binding to platelets of patients with acute cerebral ischemic stroke.
Topics: Aged; Aged, 80 and over; Blood Platelets; Brain; Cerebral Infarction; Functional Laterality; Hemiplegia; Humans; Middle Aged; Paresis; Platelet Activating Factor; Reference Values; Tomography, X-Ray Computed | 1999 |
Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchanges.
Topics: Antigens; Child; Factor VIII; Female; Hemiplegia; Hemolytic-Uremic Syndrome; Humans; Plasma Exchange; Platelet Activating Factor; Seizures; von Willebrand Factor | 1987 |